Regeneron Acquires 23andMe Assets for $256M to Expand Consumer Genomics and Data-Driven Drug Discovery
Regeneron has announced an agreement to acquire substantially all assets of 23andMe for $256 million, following a bankruptcy auction process. The transaction, expected to close …
Read More
